Digital Health: Page 15
-
Courtesy of Insulet Corp.
Insulet raises forecast as Omnipod 5 sales climb; Tandem expects tougher market in second half
Both insulin pump companies grew revenue by more than 10% in the second quarter, but Tandem lowered its 2022 forecast amid a tougher market, while Insulet increased its guidance.
By Ricky Zipp • Aug. 11, 2022 -
Spencer Platt/Getty Images via Getty Images
Roundup: Medical device industry confident it can ride out recession, wary of slowing capital sales
While companies may weather a recession, they still face challenges like hospital staffing shortages, supply chain disruption and inflation, RBC Capital Markets analysts wrote.
By Nick Paul Taylor • Updated Aug. 10, 2022 -
Explore the Trendline➔
Sara Silbiger via Getty Images
TrendlineTop 5 stories from MedTech Dive
From haphazard layoffs at the Food and Drug Administration to the industry’s current IPO environment and tracking FDA-authorized AI devices, here is a collection of top stories from MedTech Dive.
By MedTech Dive staff -
Naomi Eide/MedTech Dive
Senate passes $740B bill to lower healthcare costs after months of wrangling
While Republicans successfully challenged a planned $35 insulin price ceiling for patients on private insurance, the law still has implications for makers of diabetes devices.
By Nick Paul Taylor • Aug. 8, 2022 -
Sarah Silbiger via Getty Images
FDA’s breakthrough device designations poised for another record year
At the midpoint of the year, the FDA had granted 129 designations, suggesting it will break the previous full-year record of 206.
By Nick Paul Taylor • Aug. 8, 2022 -
Permission granted by iRhythm Technologies
iRhythm raises 2022 revenue forecast after record number of registrations in Q2
The cardiac monitor maker increased the low end of its forecast by $5 million, although executives expect a flat third quarter compared to the second quarter due to macroeconomic pressures.
By Ricky Zipp • Aug. 5, 2022 -
Courtesy of https://www.mementor.de/
ResMed buys Mementor for prescription digital health app, continuing German expansion
ResMed will integrate the startup into its German operation as a separate business segment and use it as a platform for further digital health development.
By Nick Paul Taylor • Aug. 4, 2022 -
Courtesy of Dexcom, Nick Jonas Super Bowl kit
Dexcom’s G7 glucose monitor delayed until late 2022; stock price drops 5.6%
The CGM maker needs to update software for the product, pushing back the FDA’s decision and eventual U.S. release.
By Ricky Zipp • July 29, 2022 -
Permission granted by Pear Therapeutics
Pear Therapeutics restructures, looks to slash development costs
The digital therapeutics company is looking to cut down on the development of new product candidates to focus on near-term commercialization plans.
By Elise Reuter • Updated July 28, 2022 -
Permission granted by iRhythm Technologies
iRhythm, Alphabet unit Verily get FDA clearances for Zio Watch and software system
Bolstered by an AI algorithm, the companies’ partnership is a step closer to catching up with the Apple Watch.
By Ricky Zipp • July 25, 2022 -
Getty Images
Sponsored by OptimizeRxTurning your unique brand knowledge into stronger HCP relationships
How life science companies can translate their extensive brand knowledge into a digital, forward-looking HCP engagement strategy.
July 25, 2022 -
Getty Images
Johns Hopkins sepsis alert tool reduced patient deaths, studies find
Three prospective studies of a machine learning tool developed by a Johns Hopkins spinout found it led to earlier antibiotic treatment and reduced patient mortality.
By Elise Reuter • July 22, 2022 -
Getty Images
FDA patient advisers grapple with consent, oversight of virtual-reality devices in healthcare
The advisory group addressed patient consent in surgeries using augmented reality tools and how to distinguish clinical uses of virtual reality from entertainment products.
By Elise Reuter • July 20, 2022 -
Permission granted by iRhythm Technologies
iRhythm says Q2 unit volumes beat forecast, names Chad Patterson as new CCO
The company noted the results are preliminary and may change before its Aug. 4 earnings call.
By Ricky Zipp • July 19, 2022 -
Permission granted by DarioHealth
Lack of payment pathway clarity hinders digital therapeutics, analysts say
The report warns of a sector beset by payment issues, “snake oil” and “middling adoption.”
By Nick Paul Taylor • July 15, 2022 -
Permission granted by iRhythm Technologies
CMS proposes national rates for cardiac monitoring; iRhythm's stock jumps
The proposed rule could end a years-long saga for the cardiac market, although pricing specifics may change in the final version.
By Ricky Zipp • July 8, 2022 -
Getty Images
Semiconductor shortage leaves medtech industry 'more pessimistic' as customers leave, says Deloitte
Hospitals and health systems are looking into alternative products as a result of the disruption, according to a report from Deloitte and AdvaMed.
By Nick Paul Taylor • July 7, 2022 -
Courtesy of Fitbit
Wearables are a growing part of doctor-patient talks for cardiac patients: study
As mentions of wearables in primary care grew, Apple increasingly replaced Fitbit as the most-discussed wearable brand in talks between physicians and patients in the study, which covered the years 2005 to 2019.
By Nick Paul Taylor • July 6, 2022 -
(Photo by Dan Kitwood/Getty Images) via Getty Images
'Little sign' that digital tools are being deployed effectively in fight against COVID outbreak, study finds
To help reduce the spread of the next pandemic, there is “a substantial practical advantage” to integrating the features of multiple smartphone apps, a Scripps Research Translational Institute team found.
By Nick Paul Taylor • July 6, 2022 -
Permission granted by Apple
AliveCor ECG patent ruling sets stage for block on Apple Watch imports
Apple Watch imports to the U.S. could be barred if ruling by International Trade Court judge is finalized; Judge says Apple Watch infringes two cardiogram patents.
By Nick Paul Taylor • July 5, 2022 -
Retrieved from LiveMetric website on July 01, 2022
LiveMetric's blood-pressure 'smartwatch' device gets FDA clearance
The wristwatch-like device will be made available through health systems, insurers and self-insured employers to ease continuous monitoring of blood pressure and avoid white-coat syndrome.
By Nick Paul Taylor • July 1, 2022 -
Getty Images
Medtech M&A falls 85% but activity could rebound in second half: report
PwC highlights a range of barriers that could stop acquisitions, including supply chain issues, scrutiny from the Federal Trade Commission and geopolitical concerns.
By Nick Paul Taylor • June 24, 2022 -
Megan Quinn/MedTech Dive
Deep DiveAs cross-state telemedicine waivers expire, virtual care advocates focus on long-term policy changes
There’s a complication: No one solution to the U.S.’ patchy physician licensing infrastructure has universal buy-in.
By Rebecca Pifer • June 22, 2022 -
Getty Images
Lack of clinical evidence 'major gap' in digital health: study
The researchers framed the low scores as evidence of “a major gap in health care technology,” adding that there is a “significant opportunity” for companies that differentiate themselves with a more rigorous approach.
By Nick Paul Taylor • June 22, 2022 -
Carl Court via Getty Images
Senseonics lands CE mark for 6-month CGM implant, teeing up Q3 launch in Europe
Senseonics is looking to the longer-lasting implant to re-energize its fight in a market dominated by Abbott Laboratories and Dexcom.
By Nick Paul Taylor • June 17, 2022 -
Permission granted by Apple
Apple Watch monitoring features for AFib, Parkinson's cleared by FDA
With the new feature, atrial fibrillation patients may have an easier way to track the frequency of the condition over time and see whether lifestyle changes may have positive effects.
By Nick Paul Taylor • June 14, 2022
Previous
